- Home
- HGV vs XENE Comparison
HGV vs XENE Comparison
Compare HGV & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGV
- XENE
- Stock Information
- Founded
- HGV 1992
- XENE 1996
- Country
- HGV United States
- XENE Canada
- Employees
- HGV N/A
- XENE N/A
- Industry
- HGV Hotels/Resorts
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- HGV Consumer Discretionary
- XENE Health Care
- Exchange
- HGV Nasdaq
- XENE Nasdaq
- Market Cap
- HGV 3.8B
- XENE 3.3B
- IPO Year
- HGV N/A
- XENE 2014
- Fundamental
- Price
- HGV $40.41
- XENE $38.52
- Analyst Decision
- HGV Buy
- XENE Strong Buy
- Analyst Count
- HGV 9
- XENE 7
- Target Price
- HGV $45.22
- XENE $56.00
- AVG Volume (30 Days)
- HGV 976.5K
- XENE 424.9K
- Earning Date
- HGV 02-27-2025
- XENE 02-27-2025
- Dividend Yield
- HGV N/A
- XENE N/A
- EPS Growth
- HGV N/A
- XENE N/A
- EPS
- HGV 0.89
- XENE N/A
- Revenue
- HGV $4,238,000,000.00
- XENE N/A
- Revenue This Year
- HGV $40.56
- XENE N/A
- Revenue Next Year
- HGV $5.45
- XENE $1,600.08
- P/E Ratio
- HGV $45.26
- XENE N/A
- Revenue Growth
- HGV 18.38
- XENE N/A
- 52 Week Low
- HGV $33.21
- XENE $35.53
- 52 Week High
- HGV $49.02
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- HGV 57.57
- XENE 42.98
- Support Level
- HGV $39.17
- XENE $36.90
- Resistance Level
- HGV $40.35
- XENE $41.03
- Average True Range (ATR)
- HGV 0.88
- XENE 1.41
- MACD
- HGV 0.21
- XENE 0.03
- Stochastic Oscillator
- HGV 91.07
- XENE 30.39
About HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.